The CEO of Accelerant Holdings sold 80,000 Class A Common Shares for $1.1 million at $13.33 per share on July 6, 2026.
The disposition represents a roughly 0.3% reduction in reported equity holdings.
Sales were executed indirectly through Badly Bent LLC under a pre-arranged Rule 10b5-1 plan.
Jeffrey L. Radke, Co-Founder and CEO of Accelerant Holdings (NYSE:ARX), sold 80,000 Class A Common Shares on July 6, 2026, for approximately $1.1 million, as disclosed in a recent SEC Form 4 filing.
| Metric | Value |
|---|---|
| Transaction value | $1.1 million |
| Shares sold (indirectly held) | 80,000 |
| Post-transaction shares (total) | 28.6 million |
| Post-transaction shares (directly held) | 333,652 |
| Post-transaction shares (indirectly held) | 28.3 million |
| Post-transaction value | $379.02 million |
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-07-06) | $13.25 |
| Market Capitalization | $2.9 billion |
| Revenue (TTM) | $982.8 million |
| Net Income (TTM) | -$1.4 billion |
Accelerant Holdings operates as a specialized financial services platform within the property and casualty insurance sector. The company's competitive positioning centers on its proprietary data-driven exchange infrastructure that streamlines the connection between underwriting capacity and risk capital, addressing structural inefficiencies in the specialty insurance market. Accelerant functions as a critical intermediary in the specialty insurance value chain, enabling more efficient capital allocation and risk transfer mechanisms.
This sale ultimately looks like a founder taking a small portion of his stake off the table for what could be a plethora of reasons. Radke set the trading plan in March, and 80,000 shares is a rounding error against the roughly 28.6 million he still controls, the bulk of it held indirectly through an LLC. When a co-founder CEO parts with about three-tenths of a percent of his position under a preset schedule, the only real signal is that he has expenses like anyone else.
The business is scaling well for a company that’s been public for less than a year, even if the underlying stock has been struggling. First-quarter operating revenue jumped to $273.2 million from $174 million, exchange written premium topped $1 billion for a fourth straight quarter, and adjusted EBITDA climbed 70% to $66.1 million as Accelerant leaned into its capital-light, fee-based model. CFO Linda Huber pointed to fee-based revenue and EBITDA rising 52% and 112%, and management guided to at least $5.2 billion in exchange premium for the year. Shares took a steep hit early in their run amid partner concentration concerns and net losses, which totaled $4.1 million for the quarter compared to net income of $7.8 million, so ultimately, long-term investors should stay focused as management looks to turn the firm into “the rails on which specialty insurance run.”
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.